ELRAY RESOURCES, INC. - 27 Mar 2025 Form 4 Insider Report for 180 Life Sciences Corp. (ATNF)

Role
10%+ Owner
Signature
Elray Resources, Inc., by /s/ Anthony Brian Goodman, CEO
Issuer symbol
ATNF
Transactions as of
27 Mar 2025
Net transactions value
$0
Form type
4
Filing time
11 Apr 2025, 18:05:04 UTC
Previous filing
31 Dec 2024
Next filing
18 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ATNF Common Stock Conversion of derivative security +1,318,000 1,318,000 27 Mar 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ATNF Series B Convertible Preferred Stock Conversion of derivative security $0 -1,000,000 -100% $0.000000 0 27 Mar 2025 Common Stock 1,318,000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 27, 2025, Elray Resources, Inc., converted all 1,000,000 outstanding shares of Series B Convertible Preferred Stock of the Issuer which it then held into 1,318,000 shares of common stock (1.318 shares of common stock for each share of Series B Convertible Preferred Stock converted), in accordance with the terms of such preferred stock and the optional conversion right set forth therein.
F2 Each of the 1,000,000 shares of Series B Convertible Preferred Stock was convertible into 1.318 shares of common stock.
F3 The Series B Convertible Preferred Stock has no expiration date.